Form S-8 - Securities to be offered to employees in employee benefit plans:
SEC Accession No. 0001178913-24-004060
Filing Date
2024-12-27
Accepted
2024-12-27 16:16:24
Documents
8
Effectiveness Date
2024-12-27

Document Format Files

Seq Description Document Type Size
1 S-8 zk2432491.htm S-8 77199
2 EXHIBIT 4.1 exhibit_4-1.htm EX-4.1 165392
3 EXHIBIT 5.1 exhibit_5-1.htm EX-5.1 9453
4 EXHIBIT 23.2 exhibit_23-2.htm EX-23.2 3195
5 EXHIBIT 107 exhibit_107.htm EX-FILING FEES 16702
6 image00002.jpg GRAPHIC 3860
7 image00003.jpg GRAPHIC 4528
8 image00005.jpg GRAPHIC 13547
  Complete submission text file 0001178913-24-004060.txt   303686
Mailing Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871
Business Address 2 HAMA-AYAN STREET MODI-IN TECHNOLOGY PARK MODI-IN L3 7177871 972-2-548-9100
BioLineRx Ltd. (Filer) CIK: 0001498403 (see all company filings)

EIN.: 000000000 | State of Incorp.: L3 | Fiscal Year End: 1231
Type: S-8 | Act: 33 | File No.: 333-284059 | Film No.: 241585911
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)